原发性非小细胞肺癌患者表观扩散系数与标准化摄取值和总生存期的相关性:基于18F-FDG PET/MRI的研究
研究纳入92例初诊经病理证实的非小细胞肺癌患者,行胸部18F-FDG PET/MRI检查,测量原发肿瘤的SUVmax、SUVmean及ADCmean、ADCmin并分析其与总生存期的相关性。结果显示SUVmax(HR 2.37)和SUVmean(HR 1.85)为总生存期的独立预测因子,ADCmean的HR为2.01,而ADCmin无统计学意义。SUV与ADC的联合分析未改善预后预测效能。
要点
- 原发肿瘤SUVmax和SUVmean是初治非小细胞肺癌患者总生存期的独立预测因子。
- ADCmean的HR为2.01(95%CI 1.2-3.38,p=0.007),ADCmin无统计学意义。
- SUV与ADC联合分析未改善SUV对总生存期的预测效能。
核心结论
- 原发肿瘤的SUVmax和SUVmean是初治非小细胞肺癌患者总生存期的预测因子。
- SUV与ADC值的联合分析未改善上述预测结果,ADC值未进一步增强SUV作为预后生物标志物的诊断价值。
研究设计与样本
- 回顾性分析92例初诊经组织病理学证实的非小细胞肺癌患者(女44例、男48例,平均年龄63.1±9.9岁)。
- 所有患者接受专门的胸部18F-FDG PET/MRI检查。
- 在融合PET/MR图像上沿原发肿瘤手动勾画多边形感兴趣区(ROI),涵盖整个原发肿瘤,测定SUVmax和SUVmean;在ADC图上测定ADCmean和ADCmin。
- 采用风险比(HR)检验各参数对总生存期的预测价值,计算Pearson相关系数评估各值之间的相关性,p<0.05为差异有统计学意义。
诊断标准与关键数值
- SUVmax作为总生存期独立预测因子的HR为2.37(95%CI 1.23-4.59,p=0.008)。
- SUVmean的HR为1.85(95%CI 1.05-3.26,p=0.03)。
- ADCmean的HR为2.01(95%CI 1.2-3.38,p=0.007);ADCmin的HR为0.95(95%CI 0.57-1.59,p=0.842)。
- SUVmax/ADCmean联合分析的HR为2.01(95%CI 1.10-3.67,p=0.02);SUVmax/ADCmin的HR为1.75(95%CI 0.97-3.15,p=0.058);SUVmean/ADCmean的HR为1.78(95%CI 1.02-3.10,p=0.04)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate if the combined analysis of the apparent diffusion coefficient (ADC) and standardized uptake values (SUV) measured in 18F-fluoro-deoxy-glucose-positron emission tomography/magnetic resonance imaging (18F-FDG PET/MRI) examinations correlates with overall survival in non-small cell lung cancer (NSCLC).
MATERIAL AND METHODS: A total of 92 patients with newly diagnosed, histopathologically proven NSCLC (44 women and 48 men, mean age 63.1 ± 9.9y) underwent a dedicated thoracic 18F-FDG PET/MRI examination. A manually drawn polygonal region of interest (ROI), encompassing the entire primary tumor mass, was placed over the primary tumor on fused PET/MR images to determine the maximum and mean standardized uptake values (SUVmax; SUVmean) as well as on the ADC maps to quantify the mean and minimum ADC values (ADCmean, ADCmin). The impact of these parameters to predict patient's overall survival was tested using hazard ratios (HR). Pearson's correlation coefficients were calculated to assess dependencies between the different values. A p-value < 0.05 indicated statistical significance.
RESULTS: In all 92 patients (n = 59 dead at time of retrospective data collection, mean time till death: 19 ± 16 month, n = 33 alive, mean time to last follow-up: 56 ± 22 month) the Hazard ratios (HR) as independent predictors for overall survival (OS) of SUVmax were 2.37 (95 % CI: 1.23-4.59, p = 0.008) and for SUVmean 1.85 (95 % CI: 1.05-3.26, p = 0.03) while ADCmin showed a HR of 0.95 (95 % CI: 0.57-1.59, p = 0.842) and ADCmean a HR of 2.01 (95 % CI: 1.2-3.38, p = 0.007). Furthermore, a combined analysis for SUVmax/ADCmean, SUVmax / ADCmin and SUVmean/ADCmean revealed a HR of 2.01 (95 % CI: 1.10-3.67, p = 0.02), 1.75 (95 % CI: 0.97-3.15, p = 0.058) and 1.78 (95 % CI: 1.02-3.10, p = 0.04).
CONCLUSION: SUVmax and SUVmean of the primary tumor are predictors for OS in therapy-naive NSCLC patients, whereas the combined analysis of SUV and ADC values does not improve these results. Therefore, ADC values do not further enhance the diagnostic value of SUV as a prognostic biomarker in NSCLC.
引用
- Bruckmann NM, Kirchner J, Grueneisen J, et al. Correlation of the apparent diffusion coefficient (ADC) and standardized uptake values (SUV) with overall survival in patients with primary non-small cell lung cancer (NSCLC) using 18F-FDG PET/MRI. Eur J Radiol. 2020. PMID: 33271432. doi:10.1016/j.ejrad.2020.109422
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。